It has been shown that long-term systemic treatment of AKG effectively lowered blood glucose levels, which were associated with decreased hepatic gluconeogenesis and increased insulin secretion, in diet-induced obesity and db/db mice. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.